Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

Simple item page
dc.contributor.authorRoss, D.M.
dc.contributor.authorPagani, I.S.
dc.contributor.authorIrani, Y.D.
dc.contributor.authorClarson, J.
dc.contributor.authorLeclercq, T.
dc.contributor.authorDang, P.
dc.contributor.authorMcLean, J.
dc.contributor.authorSaunders, V.A.
dc.contributor.authorCarne, L.
dc.contributor.authorReynolds, J.
dc.contributor.authorRitchie, D.S.
dc.contributor.authorWhite, D.L.
dc.contributor.authorBranford, S.
dc.contributor.authorHughes, T.P.
dc.contributor.authorYong, A.S.M.
dc.date.issued2019
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityDavid M. Ross, Ilaria S. Pagani, Yazad D. Irani, Jade Clarson, Tamara Leclercq, Phuong Dang, Jennifer McLean, Verity A. Saunders, Lisa Carne, John Reynolds, David S. Ritchie, Deborah L. White, Susan Branford, Timothy P. Hughes, Agnes S. M. Yong
dc.identifier.citationBritish Journal of Haematology, 2019; 186(3):e56-e60
dc.identifier.doi10.1111/bjh.15894
dc.identifier.issn0007-1048
dc.identifier.issn1365-2141
dc.identifier.orcidRoss, D.M. [0000-0001-7171-2935]
dc.identifier.orcidPagani, I.S. [0000-0002-3216-2966]
dc.identifier.orcidIrani, Y.D. [0000-0002-2861-5774]
dc.identifier.orcidWhite, D.L. [0000-0003-4844-333X]
dc.identifier.orcidBranford, S. [0000-0002-1964-3626] [0000-0002-5095-7981]
dc.identifier.orcidHughes, T.P. [0000-0002-0910-3730] [0000-0002-7990-4509]
dc.identifier.orcidYong, A.S.M. [0000-0001-9452-1533]
dc.identifier.urihttp://hdl.handle.net/2440/120083
dc.language.isoen
dc.publisherJohn Wiley & Sons
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1138935
dc.rights© 2019 British Society for Haematology and John Wiley & Sons Ltd.
dc.source.urihttps://doi.org/10.1111/bjh.15894
dc.subjectchronic myeloid leukaemia
dc.subjectimmunology
dc.subjectminimal residual disease
dc.subjecttreatment-free remission
dc.titleLenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications